NKTR
Price
$24.76
Change
-$0.77 (-3.02%)
Updated
Jul 3 closing price
Capitalization
428.36M
31 days until earnings call
XBIO
Price
$3.70
Change
-$0.24 (-6.09%)
Updated
Jul 3 closing price
Capitalization
5.71M
Interact to see
Advertisement

NKTR vs XBIO

Header iconNKTR vs XBIO Comparison
Open Charts NKTR vs XBIOBanner chart's image
Nektar Therapeutics
Price$24.76
Change-$0.77 (-3.02%)
Volume$994.11K
Capitalization428.36M
Xenetic Biosciences
Price$3.70
Change-$0.24 (-6.09%)
Volume$40.95K
Capitalization5.71M
NKTR vs XBIO Comparison Chart in %
Loading...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NKTR vs. XBIO commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NKTR is a StrongBuy and XBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (NKTR: $24.76 vs. XBIO: $3.70)
Brand notoriety: NKTR: Notable vs. XBIO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NKTR: 48% vs. XBIO: 49%
Market capitalization -- NKTR: $428.36M vs. XBIO: $5.71M
NKTR [@Biotechnology] is valued at $428.36M. XBIO’s [@Biotechnology] market capitalization is $5.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NKTR’s FA Score shows that 0 FA rating(s) are green whileXBIO’s FA Score has 1 green FA rating(s).

  • NKTR’s FA Score: 0 green, 5 red.
  • XBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, XBIO is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NKTR’s TA Score shows that 6 TA indicator(s) are bullish while XBIO’s TA Score has 5 bullish TA indicator(s).

  • NKTR’s TA Score: 6 bullish, 4 bearish.
  • XBIO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, XBIO is a better buy in the short-term than NKTR.

Price Growth

NKTR (@Biotechnology) experienced а -16.58% price change this week, while XBIO (@Biotechnology) price change was -7.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($428M) has a higher market cap than XBIO($5.71M). NKTR YTD gains are higher at: 77.491 vs. XBIO (-7.268). XBIO has higher annual earnings (EBITDA): -3.88M vs. NKTR (-97.97M). NKTR has more cash in the bank: 219M vs. XBIO (5.16M). XBIO has less debt than NKTR: XBIO (153K) vs NKTR (100M). NKTR has higher revenues than XBIO: NKTR (87.2M) vs XBIO (2.58M).
NKTRXBIONKTR / XBIO
Capitalization428M5.71M7,501%
EBITDA-97.97M-3.88M2,526%
Gain YTD77.491-7.268-1,066%
P/E RatioN/AN/A-
Revenue87.2M2.58M3,376%
Total Cash219M5.16M4,241%
Total Debt100M153K65,359%
FUNDAMENTALS RATINGS
NKTR vs XBIO: Fundamental Ratings
NKTR
XBIO
OUTLOOK RATING
1..100
5049
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
3443
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XBIO's Valuation (20) in the Biotechnology industry is somewhat better than the same rating for NKTR (80). This means that XBIO’s stock grew somewhat faster than NKTR’s over the last 12 months.

XBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NKTR (100). This means that XBIO’s stock grew similarly to NKTR’s over the last 12 months.

XBIO's SMR Rating (97) in the Biotechnology industry is in the same range as NKTR (99). This means that XBIO’s stock grew similarly to NKTR’s over the last 12 months.

NKTR's Price Growth Rating (34) in the Biotechnology industry is in the same range as XBIO (43). This means that NKTR’s stock grew similarly to XBIO’s over the last 12 months.

NKTR's P/E Growth Rating (84) in the Biotechnology industry is in the same range as XBIO (100). This means that NKTR’s stock grew similarly to XBIO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NKTRXBIO
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
84%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
75%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASM3.500.13
+3.86%
Avino Silver & Gold Mines Ltd
TOST43.581.04
+2.44%
Toast
PSBD14.030.18
+1.30%
Palmer Square Capital BDC
CABO137.361.15
+0.84%
Cable One
ESGL3.10-0.07
-2.06%
ESGL Holdings Limited

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRNX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-3.02%
CRNX - NKTR
43%
Loosely correlated
+1.22%
YMAB - NKTR
41%
Loosely correlated
+0.94%
ABCL - NKTR
40%
Loosely correlated
+1.33%
AMLX - NKTR
39%
Loosely correlated
-4.11%
EYPT - NKTR
39%
Loosely correlated
+0.62%
More

XBIO and

Correlation & Price change

A.I.dvisor tells us that XBIO and ELEV have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XBIO and ELEV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XBIO
1D Price
Change %
XBIO100%
-6.09%
ELEV - XBIO
28%
Poorly correlated
+2.46%
VERA - XBIO
27%
Poorly correlated
N/A
ALT - XBIO
26%
Poorly correlated
-2.86%
NKTR - XBIO
25%
Poorly correlated
-3.02%
CGEN - XBIO
24%
Poorly correlated
+1.15%
More